Access cutting-edge chronic myeloid leukemia treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access chronic myeloid leukemia specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic myeloid leukemia treatment provided free
This is a single arm phase II study that will enroll a minimum of 47 subjects with a maximum of 51. All patients will have a confirmed diagnosis of chronic phase chronic myeloid Leukemia and must have previously attempted to discontinue Tyrosine Kinase inhibitors (TKI). All patients must have restarted the same TKI they were on prior to discontinuation at the time of relapse in order to be eligible for this trial.
Sponsor: Medical College of Wisconsin
Check if you qualify for this chronic myeloid leukemia clinical trial in Detroit, MI
If you're searching for chronic myeloid leukemia treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myeloid leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.